Skip to main content
Canna~Fangled Abstracts

Footshock-Induced Abstinence from Compulsive Methamphetamine Self-administration in Rat Model Is Accompanied by Increased Hippocampal Expression of Cannabinoid Receptors (CB1 and CB2)

By January 3, 2022No Comments
. 2022 Jan 3.

doi: 10.1007/s12035-021-02656-8.

Online ahead of print.
Subramaniam Jayanthi # 1, Ritvik Peesapati # 1, Michael T McCoy 1, Bruce Ladenheim 1, Jean Lud Cadet 2
Affiliations 

Abstract

Methamphetamine (METH) use disorder (MUD) is characterized by compulsive and repeated drug taking despite negative life consequences. Large intake of METH in humans and animals is accompanied by dysfunctions in learning and memory processes. The endocannabinoid system (ECS) is known to modulate synaptic plasticity and cognitive functions. In addition, the ECS has been implicated in some of the manifestations of substance use disorders (SUDs). We therefore sought to identify potential changes in the expression of various enzymes and of the receptors (CB1 and CB2) that are members of that system. Herein, we used a model of METH self-administration (SA) that includes a punishment phase (footshocks) that helps to separate rats into a compulsive METH phenotype (compulsive) that continues to take METH and a non-compulsive METH (abstinent) group that suppressed or stopped taking METH. Animals were euthanized 2 h after the last METH SA session and their hippocampi were used to measure mRNA levels of cannabinoid receptors (CB/Cnr), as well as those of synthesizing (DAGL-A, DAGL-B, NAPEPLD) and metabolizing (MGLL, FAAH, PTGS2) enzymes of the endocannabinoid cascade. Non-compulsive rats exhibited significant increased hippocampal expression of CB1/Cnr1 and CB2/Cnr2 mRNAs. mRNA levels of the synthesizing enzyme, DAGL-A, and of the metabolic enzymes, MGLL and FAAH, were also increased. Non-compulsive rats also exhibited a significant decrease in hippocampal Ptgs2 mRNA levels. Taken together, these observations implicate the hippocampal endocannabinoid system in the suppression of METH intake in the presence of adverse consequences.

 

Keywords: Abstinence, Addiction, Cannabinoid receptors, Endocannabinoid, Footshocks, Hippocampus, Methamphetamine, Methamphetamine use disorder, Neuroprotection

References

    1. Jones CM, Compton WM, Mustaquim D (2020) Patterns and characteristics of methamphetamine use among adults — United States, 2015–2018. MMWR Morb Mortal Wkly Rep 69(12):317–323. https://doi.org/10.15585/mmwr.mm6912a1 – DOI – PubMed – PMC
    1. Cadet JL, Krasnova IN (2009) Cellular and molecular neurobiology of brain preconditioning. Mol Neurobiol 39(1):50–61. https://doi.org/10.1007/s12035-009-8051-6 – DOI – PubMed – PMC
    1. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75(6):406–433. https://doi.org/10.1016/j.pneurobio.2005.04.003 – DOI – PubMed
    1. Beauvais G, Atwell K, Jayanthi S, Ladenheim B, Cadet JL (2011) Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. PLoS ONE 6(12):e28946. https://doi.org/10.1371/journal.pone.0028946 – DOI – PubMed – PMC
    1. Cadet JL, Jayanthi S, McCoy MT, Beauvais G, Cai NS (2010) Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets 9(5):526–538 (BSP/CDTCNSND/E-Pub/00053 [pii]) – DOI

Leave a Reply